References
- Pohl H, Sirovich B, Welch HG. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol Biomarkers Prev. 2010;19:1468–1470.
- Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381:400–412.
- Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17:2–9.
- Kocher HM, Linklater K, Patel S, et al. Epidemiological study of oesophageal and gastric cancer in south-east England. Br J Surg. 2001;88:1249–1257.
- Comprehensive Cancer Center Netherlands/Comprehensive Cancer Center South. [cited 2017 July 1]; Available from: www.cijfersoverkanker.nl
- National clinical practice guideline oesophageal cancer. [cited 2017 July 1]; Available from: www.oncoline.nl
- Crosby TD, Brewster AE, Borley A, et al. Definitive chemoradiation in patients with inoperable oesophageal carcinoma. Br J Cancer. 2004;90:70–75.
- Gwynne S, Hurt C, Evans M, et al. Definitive chemoradiation for oesophageal cancer-a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol (R Coll Radiol). 2011;23:182–188.
- Merkow RP, Bilimoria KY, McCarter MD, et al. Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States. Cancer. 2011;118:3268–3276.
- Smit JK, Muijs CT, Burgerhof JG, et al. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-east Netherlands. Ann Surg Oncol. 2013;20:1985–1992.
- Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol. 2005;23:2310–2317.
- Elsayed H, Whittle I, McShane J, et al. The influence of age on mortality and survival in patients undergoing oesophagogastrectomies. A seven-year experience in a tertiary centre. Interact Cardiovasc Thorac Surg. 2010;11:65–69.
- Pultrum BB, Bosch DJ, Nijsten MW, et al. Extended esophagectomy in elderly patients with esophageal cancer: minor effect of age alone in determining the postoperative course and survival. Ann Surg Oncol. 2010;17:1572–1580.
- van Gestel YR, Lemmens VE, de Hingh IH, et al. Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients. Ann Surg Oncol. 2013;20:371–380.
- Fritz A, Percy C, Jack A, et al. International classification of diseases for oncology. 3rd ed. Geneva (Switzerland): World Health Organisation; 2000.
- UICC: TNM Classification of malignant tumours. 6th ed. New York (NY): Wiley-Liss; 2002.
- UICC: TNM Classification of malignant tumours. 7th ed. New York (NY): Wiley-Liss; 2009.
- Koppert LB, Lemmens VE, Coebergh JW, et al. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg. 2012;99:1693–1700.
- Miyata H, Yamasaki M, Makino T, et al. Clinical outcome of esophagectomy in elderly patients with and without neoadjuvant therapy for thoracic esophageal cancer. Ann Surg Oncol. 2015;22:S794–801.
- Cijs TM, Verhoef C, Steyerberg EW, et al. Outcome of esophagectomy for cancer in elderly patients. Ann Thorac Surg. 2010;90:900–907.
- Faiz Z, Lemmens VE, Siersema PD, et al. Increased resection rates and survival among patients aged 75 years and older with esophageal cancer: a Dutch nationwide population-based study. World J Surg. 2012;36:2872–2878.
- Mak RH, Mamon HJ, Ryan DP, et al. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus. 2010;23:316–323.
- Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086–1092.
- Reid TD, Davies IL, Mason J, et al. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma. Clin Oncol (R Coll Radiol). 2012;24:617–624.
- Bedenne L, Michel P, Bouche O, et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol. 2007;25:1160–1168.
- Chiu PW, Chan AC, Leung SF, et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg. 2005;9:794–802.
- Best LM, Mughal M, Gurusamy KS. Non-surgical versus surgical treatment for oesophageal cancer. Cochrane Database Syst Rev. 2016;3:CD011498.
- Shapiro J, van Lanschot JJ, Hulshof MC, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16:1090–1098.
- van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–2084.